National Cancer Institute NCI Cancer Bulletin: A Trusted Source for Cancer Research News
June 2, 2009 • Volume 6 / Number 11

The information and links on this page are no longer being updated and are provided for reference purposes only.


Logo for the American Society of Clinical Oncology 2009 Annual Meeting Early Chemo to Prevent Ovarian Cancer Recurrence Fails to Increase Survival

A large study has found that women in remission for ovarian cancer who started chemotherapy to prevent a recurrence based on blood levels of the protein CA125 did not live longer than women who started chemotherapy only after symptoms of the disease arose.

The findings, several gynecologic cancer experts said, should influence clinical practice and make clinicians rethink how they monitor patients for recurrence and initiate additional treatments, or salvage therapies. Read more > >



  • Legislative Update

    • Senate Appropriations Subcommittee Reviews Proposed FY2010 Budget Update

    • Tutorial on Targeted Cancer Therapies Available Online
    • U.S. and Canada Collaborate on Cancer Control Web Portal


    • NCI's Pastan Awarded Feltrinelli Prize for Medicine
    • Freedman Named a DCCPS Branch Chief

The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.

For more information about cancer, call 1-800-4-CANCER or visit

NCI Cancer Bulletin staff can be reached at

Next Section >